NRG/RTOG 1112: Randomized Phase III Study of Sorafenib vs. Stereotactic Body Radiation Therapy (SBRT) Followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937)

Laura A. Dawson, K. Winter, J. Knox, A.X. Zhu, S. Krishnan, C. Guha, L.A. Kachnic, M.T. Gillin, T.S. Hong, T. Craig, A. Hosni, E. Chen, A. Noonan, E.J. Koay, R. Sinha, M.I. Lock, N. Ohri, J.A. Dorth, J. Moughan, Christopher H. Crane